Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients

Overview of attention for article published in Transplant International, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 47 X posts from 37 X users, with an upper bound of 36,828 followers.

RT @Transpl_Int: Induction with a very low dose of #ATG in non-immunized recipients is safe and associated with a lower rate of #BPAR and #…

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients https://t.co/VMGExKEJt2 https://t.co/xzj3lNayV6

RT @c_massoumipour: Happy to share our last data about induction therapy just published in @Transpl_Int @CHUnantes @CR2TI_Nantes

RT @c_massoumipour: Happy to share our last data about induction therapy just published in @Transpl_Int @CHUnantes @CR2TI_Nantes https://t.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 43 additional X posts.